Pharmaceutical giant Pfizer announced its $10 billion acquisition of Metsera on 13 th November, securing control of the ...
The introduction of AbbVie’s hepatitis C drugs in 2014 forced Gilead’s hand in the fight for market dominance in hepatitis C.
Novo Nordisk is chopping prices again for Wegovy, but doctors say the expense will remain challenging for patients without ...
New cash-paying patients can now access Wegovy/Ozempic for $199 a month. Here's what that means for Novo Nordisk stock.
Novo Nordisk is chopping prices again for its popular obesity treatment Wegovy, but doctors say the expense will remain ...
GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced two major initiatives to make ...
The Daily Overview on MSN
Medicare will cover obesity drugs under Trump deal, from $50
President Trump has successfully negotiated a groundbreaking deal to include obesity drugs under Medicare coverage, marking a ...
A White House deal with Eli Lilly & Co. and Novo Nordisk to lower the prices of their popular obesity medicines, Zepbound and ...
Under its terms, those products will be sold by their developers through a planned national online drug platform called ...
The Daily Overview on MSN
New deal could cut an obesity drug to $149 a month
President Trump recently announced a significant development in the realm of healthcare, focusing on the affordability and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results